↓ Skip to main content

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.

Overview of attention for article published in Breast Cancer Research, March 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
96 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.
Published in
Breast Cancer Research, March 2011
DOI 10.1186/bcr2833
Pubmed ID
Authors

Sanchez CG, Ma CX, Crowder RJ, Guintoli T, Phommaly C, Gao F, Lin L, Ellis MJ, Cesar G Sanchez, Cynthia X Ma, Robert J Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Li Lin, Matthew J Ellis

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 1 1%
Australia 1 1%
Unknown 92 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 26%
Student > Ph. D. Student 20 21%
Student > Master 12 13%
Professor > Associate Professor 7 7%
Student > Bachelor 7 7%
Other 20 21%
Unknown 5 5%
Readers by discipline Count As %
Agricultural and Biological Sciences 42 44%
Medicine and Dentistry 31 32%
Biochemistry, Genetics and Molecular Biology 8 8%
Chemistry 2 2%
Immunology and Microbiology 1 1%
Other 5 5%
Unknown 7 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2013.
All research outputs
#2,580,092
of 9,613,531 outputs
Outputs from Breast Cancer Research
#410
of 1,214 outputs
Outputs of similar age
#94,538
of 291,155 outputs
Outputs of similar age from Breast Cancer Research
#25
of 37 outputs
Altmetric has tracked 9,613,531 research outputs across all sources so far. This one has received more attention than most of these and is in the 57th percentile.
So far Altmetric has tracked 1,214 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,155 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.